| 标题 |
A phase III randomized controlled non-inferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) versus piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) |
| 网址 | |
| DOI | |
| 其它 |
期刊:International Journal of Infectious Diseases 作者:Junjie Li; Wei Feng; Xiang Peng; Zhengang Tang; Lianshu Ding; et al 出版日期:2024-12-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)